Larimar Therapeutics (LRMR) Retained Earnings (2016 - 2020)
Historic Retained Earnings for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to -$51.4 million.
- Larimar Therapeutics' Retained Earnings rose 8678.75% to -$51.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$51.4 million, marking a year-over-year increase of 8678.75%. This contributed to the annual value of -$23.1 million for FY2019, which is 9340.87% up from last year.
- Latest data reveals that Larimar Therapeutics reported Retained Earnings of -$51.4 million as of Q3 2020, which was up 8678.75% from -$41.1 million recorded in Q2 2020.
- Over the past 5 years, Larimar Therapeutics' Retained Earnings peaked at -$23.1 million during Q4 2019, and registered a low of -$399.9 million during Q1 2020.
- Its 5-year average for Retained Earnings is -$258.6 million, with a median of -$276.5 million in 2017.
- As far as peak fluctuations go, Larimar Therapeutics' Retained Earnings tumbled by 6608.78% in 2016, and later surged by 9340.87% in 2019.
- Over the past 5 years, Larimar Therapeutics' Retained Earnings (Quarter) stood at -$237.5 million in 2016, then dropped by 21.9% to -$289.6 million in 2017, then dropped by 21.19% to -$350.9 million in 2018, then skyrocketed by 93.41% to -$23.1 million in 2019, then crashed by 122.25% to -$51.4 million in 2020.
- Its Retained Earnings stands at -$51.4 million for Q3 2020, versus -$41.1 million for Q2 2020 and -$399.9 million for Q1 2020.